Therapeutic drug monitoring of posaconazole in hematology adults under posaconazole prophylaxis: influence of food intake

A post-marketing evaluation of posaconazole plasma concentrations in neutropenic patients with haematological malignancy receiving posaconazole prophylaxis

(2011) Alexander M. Bryant et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Exposure–Response of Posaconazole Used for Prophylaxis Against Invasive Fungal Infections: Evaluating the Need to Adjust Doses Based on Drug Concentrations in Plasma

(2010) S H Jang et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Posaconazole Therapeutic Drug Monitoring: a Reference Laboratory Experience

(2009) G. R. Thompson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Therapeutic Drug Monitoring of Posaconazole: a Monocentric Study with 54 Adults

(2009) D. Lebeaux et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Tolerability and safety profile of posaconazole: evaluation of 18 controlled studies in healthy volunteers

(2009) A. Moton et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Posaconazole: An Oral Triazole with an Extended Spectrum of Activity

(2008) Erik J Rachwalski et al.   ANNALS OF PHARMACOTHERAPY

Pharmacokinetics and Absorption of Posaconazole Oral Suspension under Various Gastric Conditions in Healthy Volunteers

(2008) G. Krishna et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications

(2008) D. Andes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES

Pharmacokinetics of Oral Posaconazole in Neutropenic Patients Receiving Chemotherapy for Acute Myelogenous Leukemia or Myelodysplastic Syndrome

(2008) Gopal Krishna et al.   PHARMACOTHERAPY